Carrick Therapeutics to Present Clinical Data on Samuraciclib (CT7001), a First-In-Class Inhibitor of CDK7, at the 2021 San Antonio Breast Cancer Symposium

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing